Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-04

FDA Approved: BACLOFEN — Original Application (Wilshire Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved an Original Application for baclofen by Wilshire Pharmaceuticals, authorizing its use for treating spasticity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

ORIG AP for BACLOFEN (BACLOFEN)